Novartis AG
Diamino pyridine derivatives

Last updated:

Abstract:

The present invention describes novel diamino pyridine derivatives exhibiting JAK modulating properties. The present invention also relates to pharmaceutical compositions comprising these novel compounds, methods of using said compounds in the treatment of various diseases and disorders being susceptible to JAK modulation, and processes for preparing the compounds described hereinafter.

Status:
Grant
Type:

Utility

Filling date:

24 Nov 2016

Issue date:

25 Feb 2020